[go: up one dir, main page]

AR028204A1 - ELECTRO-THREADED PHARMACEUTICAL COMPOSITIONS - Google Patents

ELECTRO-THREADED PHARMACEUTICAL COMPOSITIONS

Info

Publication number
AR028204A1
AR028204A1 ARP010100354A ARP010100354A AR028204A1 AR 028204 A1 AR028204 A1 AR 028204A1 AR P010100354 A ARP010100354 A AR P010100354A AR P010100354 A ARP010100354 A AR P010100354A AR 028204 A1 AR028204 A1 AR 028204A1
Authority
AR
Argentina
Prior art keywords
electro
threaded
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
ARP010100354A
Other languages
Spanish (es)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR028204A1 publication Critical patent/AR028204A1/en

Links

Classifications

    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • D01D5/0038—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion the fibre formed by solvent evaporation, i.e. dry electro-spinning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00—Formation of filaments, threads, or the like
    • D01D5/0007—Electro-spinning
    • D01D5/0015—Electro-spinning characterised by the initial state of the material
    • D01D5/0023—Electro-spinning characterised by the initial state of the material the material being a polymer melt
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F1/00—General methods for the manufacture of artificial filaments or the like
    • D01F1/02—Addition of substances to the spinning solution or to the melt
    • D01F1/10—Other agents for modifying properties

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Textile Engineering (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Mechanical Engineering (AREA)
  • Toxicology (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Manufacturing & Machinery (AREA)
  • Psychiatry (AREA)
ARP010100354A 2000-01-28 2001-01-26 ELECTRO-THREADED PHARMACEUTICAL COMPOSITIONS AR028204A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17868200P 2000-01-28 2000-01-28

Publications (1)

Publication Number Publication Date
AR028204A1 true AR028204A1 (en) 2003-04-30

Family

ID=22653497

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010100354A AR028204A1 (en) 2000-01-28 2001-01-26 ELECTRO-THREADED PHARMACEUTICAL COMPOSITIONS

Country Status (18)

Country Link
EP (1) EP1251829A4 (en)
JP (1) JP2003521493A (en)
KR (1) KR100806412B1 (en)
CN (1) CN1223340C (en)
AR (1) AR028204A1 (en)
AU (1) AU772830B2 (en)
BR (1) BR0107869A (en)
CA (1) CA2396640A1 (en)
HU (1) HUP0301130A3 (en)
IL (1) IL150642A0 (en)
MX (1) MXPA02007298A (en)
MY (1) MY129356A (en)
NO (1) NO20023338L (en)
NZ (1) NZ519992A (en)
PL (1) PL356924A1 (en)
TW (1) TWI289061B (en)
WO (1) WO2001054667A1 (en)
ZA (1) ZA200205989B (en)

Families Citing this family (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615373B2 (en) 1999-02-25 2009-11-10 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen and tissue engineering
GB9910505D0 (en) 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
CA2464092C (en) * 2000-10-18 2013-03-12 Virginia Commonwealth University Intellectual Property Foundation Electroprocessing in drug delivery and cell encapsulation
JP2010163435A (en) * 2000-11-17 2010-07-29 Virginia Commonwealth Univ Intellectual Property Foundation Electroprocessed collagen
AU2002225700A1 (en) * 2000-11-17 2002-05-27 Virginia Commonwealth University Intellectual Property Foundation Electroprocessed collagen
US20020084178A1 (en) 2000-12-19 2002-07-04 Nicast Corporation Ltd. Method and apparatus for manufacturing polymer fiber shells via electrospinning
US7244272B2 (en) 2000-12-19 2007-07-17 Nicast Ltd. Vascular prosthesis and method for production thereof
JP2004530054A (en) * 2001-03-20 2004-09-30 ナイキャスト リミテッド Method and apparatus for improving the mechanical properties of nonwoven materials
US6685956B2 (en) * 2001-05-16 2004-02-03 The Research Foundation At State University Of New York Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications
GB0123951D0 (en) * 2001-10-05 2001-11-28 Glaxo Group Ltd Therapies for treating respiratory diseases
JP2005523262A (en) 2002-02-01 2005-08-04 ファイザー・プロダクツ・インク Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming substances
KR100549140B1 (en) * 2002-03-26 2006-02-03 이 아이 듀폰 디 네모아 앤드 캄파니 Ultra-fine nanofiber web manufacturing method by electro-blowing
US8367570B2 (en) 2002-04-04 2013-02-05 The University Of Akron Mechanically strong absorbent non-woven fibrous mats
AU2003228460A1 (en) 2002-04-04 2003-10-27 The University Of Akron Non-woven fiber assemblies
AU2003221677A1 (en) * 2002-04-11 2003-10-27 Secant Medical, Inc. Covering process using electrospinning of very small fibers
TW200410714A (en) * 2002-08-07 2004-07-01 Smithkline Beecham Corp Electrospun amorphous pharmaceutical compositions
US20060083784A1 (en) * 2002-08-07 2006-04-20 Smithkline Beecham Corporation Amorphous pharmaceutical compositions
WO2004062697A2 (en) 2003-01-07 2004-07-29 Tufts University Silk fibroin materials and use thereof
JP2007501218A (en) 2003-08-04 2007-01-25 ファイザー・プロダクツ・インク Pharmaceutical composition of adsorbate of amorphous drug and lipophilic microphase-forming substance
EP1701704A2 (en) 2003-12-31 2006-09-20 Pfizer Products Inc. Solid compositions of low-solubility drugs and poloxamers
JP4526851B2 (en) * 2004-03-31 2010-08-18 明彦 谷岡 Polysaccharide nanoscale fibers and compacts
WO2006006746A1 (en) * 2004-07-09 2006-01-19 Hak-Yong Kim Polymer particles, and a method for manufacturing the same
CN100577720C (en) * 2005-03-21 2010-01-06 中国科学院化学研究所 Biodegradable and absorbable polymer nanofiber membrane material and its preparation method and use
JP2006299459A (en) * 2005-04-20 2006-11-02 National Institute For Materials Science Method for producing biodegradable polymer non-woven tube
CN1300393C (en) * 2005-07-01 2007-02-14 中国科学院长春应用化学研究所 Preparation method of ultrafine fiber medical agent type emulsion electro spinning fiber
US20090107495A1 (en) * 2005-07-21 2009-04-30 National Institute For Materials Science Device for inhalation of medicine
JP4787585B2 (en) * 2005-09-29 2011-10-05 帝人株式会社 Manufacturing method of fiber structure by electrostatic spinning method
CN100556399C (en) * 2005-12-23 2009-11-04 中国科学院广州化学研究所 A kind of intestine target medicinal controlled release fiber and preparation method thereof
US8367112B2 (en) 2006-02-28 2013-02-05 Alkermes Pharma Ireland Limited Nanoparticulate carverdilol formulations
KR100824719B1 (en) * 2006-09-04 2008-04-24 주식회사 아모메디 Biodegradable food packaging material consisting of starch-containing nanofiber nonwoven fabric and its manufacturing method
US8765170B2 (en) 2008-01-30 2014-07-01 The Procter & Gamble Company Personal care composition in the form of an article
US9233080B2 (en) * 2008-03-27 2016-01-12 Agigma, Inc. Compositions and methods for the delivery of agents
AU2009236166A1 (en) 2008-04-16 2009-10-22 The Procter & Gamble Company Non-lathering personal care composition in the form of an article
EP2684562A1 (en) 2008-08-08 2014-01-15 Basf Se Fibre layer with an active substance on the basis of bio-polymers, applications of same and method for their manufacture
JP2011530661A (en) * 2008-08-08 2011-12-22 ビーエーエスエフ ソシエタス・ヨーロピア Active ingredient-containing fiber surface structure with controlled release of active ingredient, its use and method for its production
CN101721751B (en) * 2008-10-10 2013-01-02 张阳德 Human tissue engineering support loaded with controlled-release cell growth factor and provided with hollow silicon dioxide ball with kernel and preparation method and applications thereof
US20100291182A1 (en) * 2009-01-21 2010-11-18 Arsenal Medical, Inc. Drug-Loaded Fibers
KR101065255B1 (en) * 2009-02-13 2011-09-16 김근형 New Drug Delivery System Using Electrospinning of Biodegradable Polymers
CN101559242B (en) * 2009-05-22 2015-07-29 广州迈普再生医学科技有限公司 A kind of can simultaneously as the nano artificial cerebral dura mater and preparation method thereof of drug controlled release system
WO2011029777A1 (en) 2009-09-11 2011-03-17 Basf Se Methods for producing coated polymer fibers
JP5639659B2 (en) 2009-12-08 2014-12-10 ザ プロクター アンド ギャンブルカンパニー Porous dissolvable solid substrate and surface residual coating containing matrix microspheres
US9173826B2 (en) 2010-02-16 2015-11-03 The Procter & Gamble Company Porous, dissolvable solid substrate and surface resident coating comprising a zync pyrithione
CN101816627B (en) * 2010-04-16 2012-03-07 浙江大学 Synergistic treatment type multi-material sustained-release eye drop and preparation method
EP2588288B1 (en) 2010-07-02 2015-10-28 The Procter and Gamble Company Process for making films from nonwoven webs
CN102971453B (en) * 2010-07-02 2015-08-12 宝洁公司 Comprise their method of the long filament of non-flavorants activating agent, nonwoven web and preparation
CN103025930B (en) 2010-07-02 2014-11-12 宝洁公司 Method for delivering an active agent
EP2588659B1 (en) * 2010-07-02 2016-03-16 The Procter and Gamble Company Filaments comprising an ingestible active agent nonwoven webs and methods for making same
US20180163325A1 (en) 2016-12-09 2018-06-14 Robert Wayne Glenn, Jr. Dissolvable fibrous web structure article comprising active agents
US20120021026A1 (en) 2010-07-02 2012-01-26 Glenn Jr Robert Wayne Dissolvable Fibrous Web Structure Article Comprising Active Agents
MX345025B (en) 2010-07-02 2017-01-12 Procter & Gamble Detergent product.
EP2588091B1 (en) 2010-07-02 2020-04-15 The Procter and Gamble Company Methods of delivering a health care active by administering personal health care articles comprising a filament
CA2803629C (en) 2010-07-02 2015-04-28 The Procter & Gamble Company Filaments comprising an active agent nonwoven webs and methods for making same
CN101915797B (en) * 2010-07-27 2011-09-28 北京师范大学 Method for preparing electrostatic spinning immobilized laccase electrode
WO2012070028A1 (en) 2010-11-26 2012-05-31 University Of The Witwatersrand, Johannesburg A pharmaceutical dosage form
WO2012084427A1 (en) 2010-12-22 2012-06-28 Unilever Nv Compositions comprising structured non-aqueous liquid phase
WO2012084441A1 (en) 2010-12-22 2012-06-28 Unilever Nv Compositions in the form of fibres
CZ201124A3 (en) 2011-01-17 2012-06-13 Elmarco S.R.O. Carrier for oromucosal, especially sublingual application of physiologically active compounds
CN102251317B (en) * 2011-05-18 2013-01-16 东华大学 Preparation method of electrospun fibers with controllable drug release
WO2013124869A2 (en) * 2012-02-21 2013-08-29 Amrita Vishwa Vidyapeetham University The art, method,manner process and system of fibrous bio-degradable polymeric wafers for the local delivery of therapeutic agents in combinations
CN102631715A (en) * 2012-05-04 2012-08-15 江南大学 Preparation method of anti-coagulation nano fiber membrane
CN102670483B (en) * 2012-05-09 2014-04-02 上海交通大学 Electrostatic spinning fiber membrane preparation for treating hyperlipidemia and preparation method thereof
CN102697727B (en) * 2012-06-12 2014-01-08 东华大学 A method for preparing self-assembled ketoprofen liposomes using electrospinning technology
KR101454360B1 (en) 2012-08-31 2014-10-24 서울대학교산학협력단 A gelatin nanofibrous web containing Phaeodactylum triconutum extracts and wound dressing using the same
CN104884037B (en) 2012-10-12 2018-02-16 宝洁公司 The personal care composition of soluble preparation form
WO2014131376A1 (en) * 2013-02-26 2014-09-04 Elmarco S.R.O. Electrospun nanofibers comprising pharmaceutically active agents
CN105246469A (en) 2013-03-12 2016-01-13 活性纤维有限公司 Nanofibre and bioactive compositions and related methods
EP2813212A1 (en) 2013-06-10 2014-12-17 Zentiva, a.s. Drug formulation using API in nanofibers
US10202636B2 (en) 2013-12-24 2019-02-12 General Electric Company Electrospun fibers for protein stabilization and storage
MX2016013616A (en) 2014-04-22 2017-02-28 Procter & Gamble Compositions in the form of dissolvable solid structures.
US9937111B2 (en) 2014-05-05 2018-04-10 The Procter & Gamble Company Consumer product comprising a fibrous web solid structure with a silicone conditioning agent coating
US9827173B2 (en) 2014-05-05 2017-11-28 The Procter & Gamble Company Porous dissolvable solid structure with two benefit agents and methods of forming an aqueous treatment liquor therefrom
US9877899B2 (en) 2014-05-05 2018-01-30 The Procter & Gamble Company Consumer product comprising a fibrous web structure with a silicone conditioning agent coating
US9867762B2 (en) 2014-05-05 2018-01-16 The Procter & Gamble Company Consumer product comprising a porous dissolvable solid structure and silicone conditioning agent coating
US9861559B2 (en) 2014-05-05 2018-01-09 The Procter & Gamble Company Consumer product comprising a porous, dissolvable, fibrous web solid structure with a silicone coating
US9861558B2 (en) 2014-05-05 2018-01-09 The Procter & Gamble Company Methods of forming an aqueous treatment liquor by dissolving a porous solid with a benefit agent coating
SG10201808743VA (en) * 2014-06-10 2018-11-29 Dermtreat Aps Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
CN105362269A (en) * 2014-09-01 2016-03-02 天津药物研究院 Saccharose containing roflumilast tablets and preparation method thereof
JPWO2016159240A1 (en) * 2015-03-31 2018-02-01 Ｏｒｔｈｏｒｅｂｉｒｔｈ株式会社 Method for producing biodegradable fiber material containing drug using electrospinning
BR112018000399A2 (en) * 2015-07-07 2018-09-11 Nat Univ Singapore method for preparing a polymeric product, polymeric product, polymeric cell or tissue culture product and polymeric coating solution
CN105327357B (en) * 2015-10-14 2019-01-11 北京科技大学 A kind of drug-loading system of hyaluronic acid and preparation method thereof of catechol modification
EP3334412B1 (en) * 2015-11-19 2021-10-20 Afyx Therapeutics A/S A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site
BR112018015367A2 (en) * 2016-01-27 2018-12-18 Instar Tech A S nanofiber oromucosal carriers for therapeutic treatment
CN105727358B (en) * 2016-02-23 2019-01-22 广西易得佳医疗器械有限公司 Drug-loaded biological high-molecular composite nanometer tunica fibrosa and preparation method thereof
CN105663025A (en) * 2016-02-29 2016-06-15 浙江工业大学 Drug-containing microfilament and preparation method thereof
WO2018133910A1 (en) 2017-01-23 2018-07-26 Dermtreat Aps Method for preparing electrospun fibers with a high content of a bioadhesive substance
RU2019125715A (en) 2017-01-23 2021-02-24 Афикс Терапьютикс А/С METHOD FOR PRODUCING TWO-LAYER PRODUCT BASED ON ELECTRICALLY SPOTTED FIBERS
EP4245296B1 (en) 2017-01-27 2024-07-17 The Procter & Gamble Company Compositions in the form of dissolvable solid structures
WO2018140675A1 (en) 2017-01-27 2018-08-02 The Procter & Gamble Company Compositions in the form of dissolvable solid structures comprising effervescent agglomerated particles
CN110650723A (en) 2017-05-16 2020-01-03 宝洁公司 Conditioning hair care compositions in soluble solid structured form
CN107447366A (en) * 2017-08-03 2017-12-08 东华大学 A kind of sensitive medicament-carried sustained release nano fiber films of pH and its preparation method and application
US11053466B2 (en) 2018-01-26 2021-07-06 The Procter & Gamble Company Water-soluble unit dose articles comprising perfume
WO2019147523A1 (en) 2018-01-26 2019-08-01 The Procter & Gamble Company Water-soluble articles and related processes
KR20200085891A (en) 2018-01-26 2020-07-15 더 프록터 앤드 갬블 캄파니 Water soluble unit dose article containing fragrance
US11193097B2 (en) 2018-01-26 2021-12-07 The Procter & Gamble Company Water-soluble unit dose articles comprising enzyme
WO2019168829A1 (en) 2018-02-27 2019-09-06 The Procter & Gamble Company A consumer product comprising a flat package containing unit dose articles
JP7121944B2 (en) * 2018-05-07 2022-08-19 国立大学法人信州大学 Nanofiber and its manufacturing method
JP1629688S (en) 2018-07-16 2019-04-15
US10982176B2 (en) 2018-07-27 2021-04-20 The Procter & Gamble Company Process of laundering fabrics using a water-soluble unit dose article
US11666514B2 (en) 2018-09-21 2023-06-06 The Procter & Gamble Company Fibrous structures containing polymer matrix particles with perfume ingredients
US12234431B2 (en) 2018-10-03 2025-02-25 The Procter & Gamble Company Water-soluble unit dose articles comprising water-soluble fibrous structures and particles
CN113748195B (en) 2019-01-28 2024-01-19 宝洁公司 Recyclable, renewable or biodegradable packaging
EP3712237A1 (en) 2019-03-19 2020-09-23 The Procter & Gamble Company Fibrous water-soluble unit dose articles comprising water-soluble fibrous structures
JP7513623B2 (en) 2019-03-19 2024-07-09 ザ プロクター アンド ギャンブル カンパニー Method for reducing malodors on fabrics
CN114206307B (en) 2019-06-28 2024-08-23 宝洁公司 Soluble solid fibrous article comprising anionic surfactant
CN114025738A (en) 2019-07-03 2022-02-08 宝洁公司 Fibrous structures comprising cationic surfactants and soluble acids
USD939359S1 (en) 2019-10-01 2021-12-28 The Procter And Gamble Plaza Packaging for a single dose personal care product
WO2021077133A1 (en) 2019-10-14 2021-04-22 The Procter & Gamble Company Biodegradable and/or home compostable sachet containing a solid article
CA3157576A1 (en) 2019-11-20 2021-05-27 The Procter & Gamble Company Porous dissolvable solid structure
CN114929182B (en) 2019-12-01 2024-05-28 宝洁公司 Hair conditioning composition having a preservative system containing sodium benzoate and glycols and/or glycerides
US20230081596A1 (en) * 2020-02-13 2023-03-16 Bakel S.R.L. Method of electrospinning natural polymers
IT202000002833A1 (en) * 2020-02-13 2021-08-13 Bakel S R L ELECTRO-THREADING PROCESS
USD941051S1 (en) 2020-03-20 2022-01-18 The Procter And Gamble Company Shower hanger
USD962050S1 (en) 2020-03-20 2022-08-30 The Procter And Gamble Company Primary package for a solid, single dose beauty care composition
USD965440S1 (en) 2020-06-29 2022-10-04 The Procter And Gamble Company Package
MX2023001042A (en) 2020-07-31 2023-02-16 Procter & Gamble Water-soluble fibrous pouch containing prills for hair care.
EP4196233A1 (en) 2020-08-11 2023-06-21 The Procter & Gamble Company Moisturizing hair conditioner compositions containing brassicyl valinate esylate
EP4196235A1 (en) 2020-08-11 2023-06-21 The Procter & Gamble Company Low viscosity hair conditioner compositions containing brassicyl valinate esylate
MX2023001043A (en) 2020-08-11 2023-02-16 Procter & Gamble CLEAN RINSE CONDITIONING COMPOSITIONS FOR HAIR CONTAINING BRASSCYL VALINATE ESILATE.
JP7605842B2 (en) 2020-08-19 2024-12-24 ザ プロクター アンド ギャンブル カンパニー FLEXIBLE POROUS DISSOLVEABLE SOLID SHEET ARTICLE CONTAINING DIRECT-LOAD MICROCAPSULES AND METHODS FOR MAKING SAME - Patent application
US11672748B2 (en) 2020-12-01 2023-06-13 The Procter & Gamble Company Aqueous hair conditioner compositions containing solubilized anti-dandruff actives
USD1045064S1 (en) 2020-12-17 2024-10-01 The Procter & Gamble Company Single-dose dissolvable personal care unit
CN113041230B (en) * 2021-03-23 2022-06-24 浙江尖峰健康科技有限公司 Capsule shell of soft capsule and soft capsule prepared from capsule shell
KR102653460B1 (en) * 2021-09-01 2024-03-29 한남대학교 산학협력단 A method for manufacturing starch nanofiber comprising collagen and lecithin with controlled degradability
JPWO2023145886A1 (en) * 2022-01-31 2023-08-03
CN114808184A (en) * 2022-03-11 2022-07-29 深圳市法鑫忠信新材料有限公司 Long-acting mosquito-repelling electrostatic spinning fiber and preparation method and application thereof
CN115887422B (en) * 2022-12-31 2024-06-07 兰州交通大学 A lappaconitine knee joint analgesic sustained-release patch and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1527592A (en) * 1974-08-05 1978-10-04 Ici Ltd Wound dressing
US4855326A (en) * 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
US5567439A (en) * 1994-06-14 1996-10-22 Fuisz Technologies Ltd. Delivery of controlled-release systems(s)
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
US5980941A (en) * 1997-08-20 1999-11-09 Fuisz Technologies Ltd. Self-binding shearform compositions
US6753454B1 (en) * 1999-10-08 2004-06-22 The University Of Akron Electrospun fibers and an apparatus therefor

Also Published As

Publication number Publication date
EP1251829A1 (en) 2002-10-30
NO20023338D0 (en) 2002-07-11
BR0107869A (en) 2002-11-05
TWI289061B (en) 2007-11-01
NO20023338L (en) 2002-09-03
WO2001054667A1 (en) 2001-08-02
EP1251829A4 (en) 2009-05-06
PL356924A1 (en) 2004-07-12
CN1223340C (en) 2005-10-19
KR100806412B1 (en) 2008-02-21
ZA200205989B (en) 2003-02-03
MY129356A (en) 2007-03-30
JP2003521493A (en) 2003-07-15
HUP0301130A2 (en) 2003-09-29
NZ519992A (en) 2004-04-30
IL150642A0 (en) 2003-02-12
CA2396640A1 (en) 2001-08-02
HUP0301130A3 (en) 2006-07-28
AU3113401A (en) 2001-08-07
CN1396823A (en) 2003-02-12
MXPA02007298A (en) 2002-12-09
KR20020082212A (en) 2002-10-30
AU772830B2 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
AR028204A1 (en) ELECTRO-THREADED PHARMACEUTICAL COMPOSITIONS
FI20105657L (en) Pharmaceutical compositions
ITMI20010748A0 (en) PHARMACEUTICAL COMPOSITIONS
DK1524266T3 (en) Pharmaceutical composition
FI20011478L (en) Pharmaceutical composition
NO20025450L (en) New pharmaceutical composition
ATE303787T1 (en) SHEARGEL COMPOSITIONS
ITTO20010008A0 (en) PHARMACEUTICAL FORMULATION
PT1242087E (en) PHARMACEUTICAL COMPOSITIONS
AR028197A1 (en) ANTITRANSPIRING COMPOSITIONS
NO20033556L (en) Pharmaceutical Formulations
AT7729U3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AMLODIPINMALEAT
EE05020B1 (en) The pharmaceutical composition of G1buride
EE200300589A (en) Pharmaceutical compositions
NO20026123L (en) Pharmaceutical compositions
ATE369830T1 (en) SWEAT-INHIBITING COMPOSITIONS
ATE314049T1 (en) SWEAT-INHIBITING COMPOSITIONS
FI20022128A0 (en) Pharmaceutical composition
NO20031095L (en) Pharmaceutical compositions
PT1239832E (en) PHARMACEUTICAL COMPOSITIONS
DE60116858D1 (en) COMPOSITION
MXPA03001857A (en) MEDICINAL COMPOSITIONS.
EE200200689A (en) Pharmaceutical compositions
DE60135223D1 (en) SHAMPOO COMPOSITIONS
EP1413314A4 (en) MEDICINAL COMPOSITION

Legal Events

Date Code Title Description
FB Suspension of granting procedure